OraSure Technologies Inc
NASDAQ:OSUR
Intrinsic Value
OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical... [ Read More ]
The intrinsic value of one OSUR stock under the Base Case scenario is 4.55 USD. Compared to the current market price of 5.25 USD, OraSure Technologies Inc is Overvalued by 13%.
Valuation Backtest
OraSure Technologies Inc
Run backtest to discover the historical profit from buying and selling OSUR stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
OraSure Technologies Inc
Current Assets | 386.5m |
Cash & Short-Term Investments | 290.4m |
Receivables | 40.2m |
Other Current Assets | 55.9m |
Non-Current Assets | 96.4m |
PP&E | 58.3m |
Intangibles | 36.9m |
Other Non-Current Assets | 1.2m |
Current Liabilities | 39.5m |
Accounts Payable | 13.2m |
Accrued Liabilities | 24.3m |
Other Current Liabilities | 2.1m |
Non-Current Liabilities | 12.6m |
Long-Term Debt | 226k |
Other Non-Current Liabilities | 12.4m |
Earnings Waterfall
OraSure Technologies Inc
Revenue
|
405.5m
USD
|
Cost of Revenue
|
-233m
USD
|
Gross Profit
|
172.5m
USD
|
Operating Expenses
|
-125.2m
USD
|
Operating Income
|
47.3m
USD
|
Other Expenses
|
6.4m
USD
|
Net Income
|
53.7m
USD
|
Free Cash Flow Analysis
OraSure Technologies Inc
What is Free Cash Flow?
OSUR Profitability Score
Profitability Due Diligence
OraSure Technologies Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.
Score
OraSure Technologies Inc's profitability score is 47/100. The higher the profitability score, the more profitable the company is.
OSUR Solvency Score
Solvency Due Diligence
OraSure Technologies Inc's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Score
OraSure Technologies Inc's solvency score is 87/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
OSUR Price Targets Summary
OraSure Technologies Inc
According to Wall Street analysts, the average 1-year price target for OSUR is 7.84 USD with a low forecast of 6.57 USD and a high forecast of 9.45 USD.
Ownership
OSUR Insider Trading
Buy and sell transactions by insiders
Period | Sold | Bought | Net |
---|---|---|---|
3 Months |
|
|
|
6 Months |
|
|
|
9 Months |
|
|
|
12 Months |
|
|
|
Shareholder Return
OSUR Price
OraSure Technologies Inc
Average Annual Return | -10.4% |
Standard Deviation of Annual Returns | 37.04% |
Max Drawdown | -86% |
Market Capitalization | 386m USD |
Shares Outstanding | 75 013 000 |
Percentage of Shares Shorted | 4.83% |
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. The company is headquartered in Bethlehem, Pennsylvania and currently employs 785 full-time employees. The firm's products include molecular sampling kits for the genome and microbiome services and analytics, rapid diagnostics for infectious disease, and tests for substance abuse. OraSure’s segments include Diagnostics segment and Molecular Collection Systems segment. The Diagnostics business primarily consists of the development, manufacture, marketing and sale of oral fluid diagnostic products and specimen collection devices. The Molecular Solutions business consists of the manufacture and sale of kits that are used to collect, stabilize, transport and store biological samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, infectious disease diagnostics, pharmacogenomics, personalized medicine, microbiome and animal genetics markets.
Contact
IPO
Employees
Officers
The intrinsic value of one OSUR stock under the Base Case scenario is 4.55 USD.
Compared to the current market price of 5.25 USD, OraSure Technologies Inc is Overvalued by 13%.